Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
5
×
deals
5
×
life sciences
national blog main
boston blog main
boston top stories
investing
san francisco blog main
fda
new york blog main
new york top stories
san francisco top stories
startups
biotech ipos
boston
cancer immunotherapy
gene editing
medical device
national
national top stories
rare diseases
renaissance capital
10x genomics
480 biomedical
abbvie
acute myeloid leukemia
allergan
alx oncology
alzheimer's disease
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
arsenal medical
autoimmune diseases
avrobio
berkeley lights
bob langer
boulder/denver blog main
boulder/denver top stories
What
biotech
5
×
ipo
companies
days
life
markets
new
public
raised
research
science
street
wall
way
week
welcomed
abbvie
ahead
alliance
ambien
american
annual
arrival
asco
attendees
attention
boost
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
company
debut
developing
drug
editas
Language
unset
Current search:
biotech
×
deals
×
" clinical trials "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
